- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03580785
Primary Failure of Eruption (PFE) : Highlighting of Clinical, Radiological and Genetic Diagnostic Criteria: Consequences on the Therapeutic Management
August 18, 2023 updated by: University Hospital, Strasbourg, France
The primary purpose of the study is to identify clinical, radiological and genetic diagnostic criteria for Primary Failure of Eruption (PFE).
The secondary purposes are to highlight the genotype-phenotype correlations in the PTHR1 and non-PTHR1 forms and analyze the therapeutic failures.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Marion STRUB, Doctor
- Phone Number: 0033 388116956
- Email: marion.strub@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67000
- Recruiting
- Clinique dentaire
-
Contact:
- Marion Strub
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria:
- people over 6 years old
- people with Primary Failure Eruption
Exclusion criteria:
- children under 6 years old
- endocrine pathology that may interfere with dental eruption
- rickets
- chemotherapy / radiotherapy
- bisphosphonate treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of teeth
Time Frame: at inclusion (day 1)
|
number of teeth
|
at inclusion (day 1)
|
Recording of dental caries
Time Frame: at inclusion (day 1)
|
recording of dental caries by Decayed Missing Filled Teeth index (DMFT index)
|
at inclusion (day 1)
|
Recording the location of dental caries
Time Frame: at inclusion (day 1)
|
the number of teeth affected using the international classification index
|
at inclusion (day 1)
|
Drugs intra uterine exposure
Time Frame: at inclusion (day 1)
|
drugs during pregnancy
|
at inclusion (day 1)
|
Nutritional deficiencies
Time Frame: at inclusion (day 1)
|
nutritional deficiencies assessed by a questionnaire
|
at inclusion (day 1)
|
Periodontium
Time Frame: at inclusion (day 1)
|
assessment of the periodontium by Maynard and Wilson classification
|
at inclusion (day 1)
|
Oral hygiene
Time Frame: at inclusion (day 1)
|
assesment of oral hygiene by plaque index (Löe and Silness, 1963)
|
at inclusion (day 1)
|
Gingival inflammation
Time Frame: at inclusion (day 1)
|
assesment of gingival inflammation by gingival index (Löe and Silness, 1963)
|
at inclusion (day 1)
|
Treatment needs
Time Frame: at inclusion (day 1)
|
assessment of treatment needs using Community Periodontal Index of treatment Needs (CPITN)
|
at inclusion (day 1)
|
Face shape
Time Frame: at inclusion (day 1)
|
assesment of the face shape : round, square, oval
|
at inclusion (day 1)
|
Symmetry of the face
Time Frame: at inclusion (day 1)
|
symmetry of the face (yes/no)
|
at inclusion (day 1)
|
Profile (shape)
Time Frame: at inclusion (day 1)
|
assessment of the profile (shape)
|
at inclusion (day 1)
|
Smile
Time Frame: at inclusion (day 1)
|
morphology of the smile
|
at inclusion (day 1)
|
Vertical dimension
Time Frame: at inclusion (day 1)
|
assessment of the vertical dimension: anterior infraclusion or overbite (in %)
|
at inclusion (day 1)
|
Transversal dimension
Time Frame: at inclusion (day 1)
|
assessment of the transversal dimension: posterior transversal dimension (in mm)
|
at inclusion (day 1)
|
Sagittal dimension
Time Frame: at inclusion (day 1)
|
Assessment of the sagittal dimension by Angle's classification
|
at inclusion (day 1)
|
Chewing
Time Frame: at inclusion (day 1)
|
Assessment of chewing by Plana's Functional Masticatory Angles (PFMA)
|
at inclusion (day 1)
|
Nasal breathing
Time Frame: at inclusion (day 1)
|
Assessment of nasal breathing by the Rosenthal's test
|
at inclusion (day 1)
|
Swallowing
Time Frame: at inclusion (day 1)
|
Assessment of swallowing by lingual interposition
|
at inclusion (day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mutations causing PFE
Time Frame: at inclusion (day 1)
|
at inclusion (day 1)
|
|
Type of treatment performed
Time Frame: at inclusion (day 1)
|
(orthodontics, surgery, prothesis)
|
at inclusion (day 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 22, 2018
Primary Completion (Estimated)
October 12, 2023
Study Completion (Estimated)
October 12, 2023
Study Registration Dates
First Submitted
April 5, 2018
First Submitted That Met QC Criteria
June 26, 2018
First Posted (Actual)
July 9, 2018
Study Record Updates
Last Update Posted (Actual)
August 21, 2023
Last Update Submitted That Met QC Criteria
August 18, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6641
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Failure of Eruption
-
Cairo UniversityUnknownEruption Statues of Primary Teeth in LBW Children
-
Ain Shams UniversityNot yet recruiting
-
Augusta UniversityRecruitingAltered Passive Eruption of TeethUnited States
-
Ain Shams UniversityCompletedAltered Passive Eruption of TeethEgypt
-
Ain Shams UniversityCompletedAltered Passive Eruption of Teeth | Gummy Smile | Guided SurgeryEgypt
-
Lady Davis InstituteRecruitingAcneiform Eruptions | Cancer, Treatment-RelatedCanada
-
Eskisehir Osmangazi UniversityCompletedFailure of Tooth Eruption Associated With Tooth ImpactionTurkey
-
Rustam AghazadaCompletedAltered Passive Eruption of TeethItaly
-
Massachusetts General HospitalWithdrawnOsteoarthritis of Hip | Failure of Primary THAUnited States
-
University of OklahomaUniversity of Michigan; Emory UniversityRecruitingPrimary Graft FailureUnited States
Clinical Trials on genetic analysis
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingLynch Syndrome | Relatives | Endometrial Carcinoma | Endometrial AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
University of Milano BicoccaRecruiting
-
University Hospital, MontpellierTerminated
-
CHU de ReimsCompletedProliferative Diabetic RetinopathyFrance
-
Stanford UniversityTerminatedRectal Cancer | Colon Cancer | Colonic Neoplasms | Anal CancerUnited States
-
Hospices Civils de LyonUnknownEmphysema | Pulmonary Fibrosis | Healthy Subjects | Combined Pulmonary Fibrosis and Emphysema SyndromeFrance
-
Augusta UniversityRecruitingOvarian Cancer | Endometrial Cancer | Peritoneal CancerUnited States
-
Benjamin TerrierRecruiting
-
University Hospital, RouenCompletedBreast Cancer | Colorectal Cancer | Ovarian Cancer | Pediatric Cancers | Multiple Primary Malignant TumoursFrance